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Abstract The terminology and classification of the Angino-
sus group streptococci has been inconsistent. We tested the
utility of 16S rRNA gene and tuf gene sequencing and
conventional biochemical tests for the reliable differentiation
of the Anginosus group streptococci. Biochemical testing
included Rapid ID 32 Strep, API Strep, Fluo-Card Milleri,
Wee-tabs, and Lancefield antigen typing. Altogether, 61
Anginosus group isolates from skin and soft tissue infections
and four reference strains were included. Our results showed
a good agreement between 16S rRNA gene and tuf gene
sequencing. Using the full sequence was less discriminatory
than using the first part of the 16S rRNA gene. The three
species could not be separated with the API 20 Strep test.
Streptococcus intermedius could be differentiated from the
other two species by β-galactosidase (ONPG) and β-N-
acetyl-glucosaminidase reactions. Rapid ID 32 Strep β-
glucosidase reaction was useful in separating S. anginosus
strains from S. constellatus. In conclusion, both 16S rRNA
gene and tuf gene sequencing can be used for the reliable
identification of the Anginosus group streptococci. S.
intermedius can be readily differentiated from the other two
species by phenotypic tests; however, 16S rRNA gene or tuf
gene sequencing may be needed for separating some strains
of S. constellatus from S. anginosus.
Introduction
The Anginosus group streptococci (AGS) consist of three
species, designated Streptococcus anginosus, Streptococcus
constellatus, and Streptococcus intermedius [1, 2]. Clinical
review and our studies have shown that, while the AGS are
found as normal flora in humans, these bacteria are
pathogens recognized for their role in pyogenic infections
and are strongly associated with abscess formation [3–5]. In
a recent study of 400 traumatic and surgical wound
infections, we found that species of the Anginosus group
were the predominant streptococci recovered; 71 AGS
strains were isolated from 60 specimens [6]. The AGS has
been described as a heterogenous group, and the terminol-
ogy and classification of the AGS has always been a source
of confusion [7]. An identification scheme proposed by
Whiley et al. is considered to be a standard for phenotypic
identification of the AGS [1, 8]. The 16S rRNA gene
sequencing and commercial identification kits commonly
used to identify bacteria have been inconsistent in identi-
fying the AGS [7, 9–13]. As a result, AGS strains may
often be reported out in the clinical microbiology laboratory
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as ‘viridans streptococci.’ Picard et al. described a
polymerase chain reaction (PCR)-based assay targeting the
tuf gene encoding elongation factor Tu for the specific
detection of streptococcal sequences [14]. However, only a
few AGS strains were included [14]. We tested the utility of
tuf gene sequencing identification and a battery of
biochemical tests for the identification of AGS strains to
the species level using 16S rRNA gene sequencing as a
reference method. Biochemical testing included Rapid ID
32 Strep, API Strep, Fluo-Card Milleri, Wee-tabs, and
Lancefield antigen typing.
Methods
Strains and growth conditions
Sixty-one strains isolated at the VA Wadsworth Medical
Center from patients at Olive View—UCLA Medical
Center were included. The reference strains for S.
anginosus (ATCC 33397T), S. constellatus (ATCC
27823T and ATCC 24889), and S. intermedius (ATCC
27335T) were included in the biochemical and molecular
characterization. Strains were maintained at −70°C in
double-strength skim milk before characterization. The
strains were grown at 37°C on trypticase soy blood agar
(TSA, Becton Dickinson Microbiology Systems, Sparks,
MD) under microaerophilic conditions (5% CO2). All
testing was done with 24 to 48-h-old pure cultures.
Genotypic testing
Genomic DNA was extracted and purified from bacterial
cells in the mid-logarithmic growth phase by using a
QIAamp DNA Mini Kit (Qiagen, Inc., Chatsworth, CA).
The 16S rRNA gene fragments were amplified by
standard methods. Two subregions of the 16S rRNA
gene were amplified by using two pairs of primers. The
first part of the 16S rRNA gene was defined as an
approximately 800-bp region between primers 8UA (5′-
AGAGTTTGATCCTGGCTCAG-3′) and 907B (5′-
CCGTCAATTCMTTTAGTTT-3′). The second part of
the 16S rRNA gene, defined as approximately 700-bp
sequences between primers 774A (5′-GTAGTCCACG
CTGTAAACGATG-3′) and 1485B (5′-TACGGTTACCT
TGTTACGAC-3′), was sequenced to obtain the complete
16S rRNA gene sequence on 22 strains (eight S.
anginosus, nine S. constellatus, and five S. intermedius).
PCR was performed for 35 cycles of 30 s at 95°C, 30 s at
45°C, and 1 min at 72°C, with a final extension at 72°C
for 5 min. The tuf gene fragments were amplified with
universal primers Tseq271 (5′-AAYATGATIACIGGIG
CIGCICARATGG-3′) and Tseq1138 (5′-CCIACIGTICK
ICCRCCYTCRCG-3′) to obtain an approximately 760-bp
portion of the gene. The PCR conditions were as follows:
95°C for 3 min; 35 cycles of 95°C for 30 s, 55°C for
1 min, and 72°C for 1 min; and a final extension of 72°C
for 5 min. The PCR products were excised from a 1%
agarose gel after electrophoresis and purified using a
QIAquick Gel Extraction Kit (Qiagen). The purified PCR
products were sequenced directly with BigDye Terminator
Cycle Sequencing Kits (Biotech Diagnostics, Tustin, CA)
on an ABI 3100 Avant Genetic System (Applied Bio-
systems, Foster City, CA). The sequencing data was
analyzed by comparison of the consensus sequences with
GenBank sequences by using the Ribosomal Database
Project (RDP-II) and the Basic Local Alignment Search
Tool software (BLAST), and the percentage similarity to
other sequences was determined. Closely related sequen-
ces were retrieved from GenBank and were aligned with
the newly determined sequences by using the program
CLUSTAL W.
Phenotypic testing
The Lancefield antigen was detected using the Streptex*
Lancefield Streptococci Latex Test (Remel, Lenexa, KS)
according to the manufacturer’s instructions. Preformed
enzyme profiles were characterized by API Strep and
Rapid ID Strep (bioMérieux, Marcy l’Etoile, France)
according to the manufacturer’s instructions using API
Suspension Medium (bioMérieux) to prepare inocula.
Fluo-Card Milleri tests were performed according to the
manufacturer’s instructions (Key Scientific Products Co.,
Stamford, TX). Additionally, Wee-tabs α-glucosidase, β-
fucosidase, β-glucosidase, β-N-acetyl-glucosaminidase
(β-NAG), esculin, and ONPG (Key Scientific Products
Co.), were included in the characterization. TSA blood
agar was used for the detection of hemolysis.
Results
Strains
Next to Staphylococcus aureus, the AGS were the second
most common isolates (71 isolates from 60 specimens; 31
S. anginosus, 28 S. constellatus, 11 S. intermedius, and
one AGS) found during our comprehensive microbiolog-
ical evaluation of 400 skin and soft tissue infections. Of
the 61 strains included in this study, 29 were S. anginosus
(sources: perirectal and torso below the diaphragm [17],
lower extremity [4], upper extremity [7], and breast [1]),
21 S. constellatus (perirectal and torso below the dia-
phragm [11], lower extremity [3], upper extremity [1], and
head and neck [6]), and 11 S. intermedius (perirectal and
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torso below the diaphragm [3], upper extremity [6], and
head and neck [2]).
Genotypic testing
The reference strains’ 16S rRNA gene sequences matched
those deposited in GenBank with 100% sequence similarity.
Similarly, for all of the clinical strains tested, the 16S rRNA
gene sequencing identified the correct species as the first
choice with ≥98% sequence similarity to the reference
strain sequences (Table 1). Twenty-eight of 29 (97%) of S.
anginosus were named with ≤2% distance from the next
named species using the first part of the 16S rRNA gene,
whereas only 4/8 (50%) S. anginosus tested were named
with ≤2% distance using the full 16S rRNA gene. Similarly,
6/21 (29%) of S. constellatus and 10/11 (91%) of S.
intermedius were named with ≤2% distance from the next
named species using the first part of the 16S rRNA gene,
but only 1/9 (11%) and 2/5 (40%), respectively, using the
full 16S rRNA gene. Further, the full 16S rRNA gene
sequence did not give discriminatory results for three S.
constellatus and two S. intermedius strains. For all of the
strains tested, the tuf gene sequencing identified the correct
species at 100–98% sequence similarity to the reference
species (Table 1). Nine of 29 (31%) of S. anginosus, 20/21
(95%) of S. constellatus, and 11/11 (100%) of S. inter-
medius were named with ≤2% distance from the next
named species by tuf gene sequencing.
Phenotypic testing
Of the 29 S. anginosus strains, two were β-hemolytic and
the rest were α-hemolytic. Most S. anginosus strains
possessed a Lancefield antigen: 16 were Lancefield group
F, six Lancefield group C, three Lancefield group G, and
four were non-typable. Of the 21 S. constellatus strains,
seven were β-hemolytic and the rest were α-hemolytic;
eight strains possessed Lancefield group F antigen, whereas
the rest had no antigen. All 11 S. intermedius isolates were
α-hemolytic, three belonged to Lancefield group F, and
eight had no antigen. The key phenotypic characteristics
obtained by the Rapid ID 32 Strep, API Strep, and Wee-tab
systems are given in Table 2. The other results are given
below. All strains were positive for arginine dihydrolase,
alkaline phosphatase, saccharose, Voges-Proskauer, alanyl-
phenylalanyl-proline arylamidase, and maltose, and all
strains were negative for β-glucuronidase, ribose, mannitol,
sorbitol, arabinose, arabitol, cyclodextrin, glycogen, mele-
zitose, and urease using the Rapid ID 32 Strep test. In
addition, S. constellatus and S. intermedius were negative
for α-galactosidase, raffinose, pyroglutamic acid arylami-
dase, hippurate, melibiose, and tagatose, whereas S.
anginosus reactions were variable. All of the strains were
positive for Voges-Proskauer, alkaline phosphatase, leucine
aminopeptidase, arginine dihydrolase, and trehalose acidi-
fication, and variable for lactose and amidon acidification
using the API Strep system. At 24 h, S. constellatus esculin
was variable. In addition, S. anginosus were occasionally
positive for α-galactosidase and ribose, arabinose, manni-
tol, inulin, and raffinose acidification. Wee-tabs α-
glucosidase, β-glucosidase, and esculin reactions were
variable with all of the strains tested.
Using the Fluo-Card Milleri, all S. intermedius strains
were β-fucosidase-positive and, thus, correctly identified
(Table 3). Only 45% of the S. anginosus strains were
correctly identified as S. anginosus; 55% of the S.
Table 1 16S rRNA and tuf gene sequencing identification of the Streptococcus anginosus group
% sequence similarity1 (next named species)
16S rRNA sequencing ID tuf gene ID
S. anginosus
ATCC 33397T 100% S. anginosus (96% S. intermedius) 100% S. anginosus (97% S. constellatus)
Clinical isolates (n=29) 100–98% S. anginosus (96–94%
S. intermedius/constellatus)
99–98% S. anginosus (98–97%
S. intermedius/constellatus)
S. constellatus
ATCC 27823T 100% S. constellatus (98% S. intermedius) 99% S. constellatus (97% S. intermedius)
ATCC 24889 100% S. constellatus (98% S. intermedius) 100% S. constellatus (98% S. intermedius)
Clinical isolates (n=21) 100–99% S. constellatus (98–97% S. intermedius) 100–99% S. constellatus (98–97%
S. anginosus/intermedius)
S. intermedius
ATCC 27335T 100% S. intermedius (98% S. constellatus/anginosus) 100% S. intermedius (96% S. constellatus/anginosus)
Clinical isolates (n=11) 100% S. intermedius (98% S. constellatus) 99–98% S. intermedius (97–96%
S. anginosus/constellatus)
1 For all of the strains tested, both the 16S rRNA gene sequencing and the tuf gene sequencing identified the correct species as the first choice
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anginosus strains were β-fucosidase-positive (but β-
glucosidase-negative). Fluo-Card Milleri identified 76% of
S. constellatus strains correctly (Table 3).
Discussion
It has been reported that there is an association between
clinical sites of infection and the different species of AGS
where S. anginosus is predominantly associated with
gastrointestinal sources, S. constellatus with all types of
abscesses, and S. intermedius with intracerebral abscesses
[3, 5, 15–17]. Our study included isolates from a skin and
soft tissue infection study only, but some general trends can
be observed from our results: S. anginosus were predom-
inantly isolated from below the diaphragm specimens,
whereas S. intermedius were mostly isolated from above
the diaphragm specimens. Also, similar to previous reports,
all of the isolates from head and neck sources were either S.
constellatus or S. intermedius [17]. Our results on the
distribution of hemolysis and Lancefield group were similar
to those previously described (Table 2) [1, 13, 17].
However, none of our β-hemolytic S. constellatus isolates
carried the Lancefield group C antigen associated with S.
constellatus subsp. pharyngis and the human throat [2].
Our results showed good agreement between the 16S
rRNA gene sequencing and tuf gene sequencing. However,
GenBank has a lot of sequences of poorly characterized
(misnamed) species. Therefore, for identification, the 16S
rRNA gene sequences must be compared only to those of
16S ID Fluo-Card reaction Fluo-Card ID
β-fucosidase β-glucosidase α-glucosidase
S. anginosus
(n=14)2 - + -+ S. anginosus (45%)
(n=16) + - + S. intermedius (55%)
S. constellatus
(n=18)2 - - +- S. constellatus (76%)
(n=5) - + -+ S. anginosus (24%)
S. intermedius
(n=11)2 + + +- S. intermedius (100%)
Table 3 Fluo-Card Milleri
identification of the S. anginosus
group1
1 + = >90% of strains are posi-
tive; - = >90% of strains are
negative; +- = 80–90% of
strains are positive; -+ = 80–
90% of strains are negative
2 Includes reference strain(s)
Table 2 Key differential phenotypic characteristics of the S. anginosus group1
S. anginosus S. constellatus S. intermedius
ATCC 33397 Clinical strains,
n=29
ATCC 27823 ATCC 24889 Clinical strains,
n=21
ATCC 27335 Clinical strains,
n=11
Lancefield antigen G F, C, G, N N N N, F N N, F
Hemolysis β α, β α α α, β α α
Rapid ID 32 STREP
β-glucosidase + + - - -+ + +
β-galactosidase - - - - - + +
β-N-acetyl-
glucosaminidase
- - - - - + +
Pullulan + +- - - - + v
β-mannosidase + v - - - + +
API Strep
Esculin (4 h) + + - - - - v
Wee-tabs
β-fucosidase - - - - - + +
β-N-acetyl-
glucosaminidase
- - - - - + +
ONPG - - - - - + +
1 N = no antigen; + = >90% of strains are positive; - = >90% of strains are negative; +- = 80–90% of strains are positive; -+ = 80–90% of strains
are negative; v = variable reaction
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well characterized reference strains in GenBank: accession
numbers AB 355609 and AF 10467 for S. anginosus; AB
355605 and AF 104676 for S. constellatus; and AF104671
for S. intermedius. Furthermore, the last part of the 16S
rRNA gene seems to be less discriminatory, and, therefore,
using the first part of the 16S rRNA gene (∼700–800 bp)
gave better results than the full 16S rRNA gene sequence
(∼1,400 bp). Picard et al. performed an extensive sequence
analysis of 28 streptococcal species and showed that tuf
gene sequencing generally resulted in better discrimination
of the species than 16S rRNA gene sequencing [14]. More
specifically, they observed that tuf gene sequencing
performed well in discriminating the AGS; however, their
study included only the type strains of the three species and
three S. anginosus clinical strains [14]. Our results expand
this observation: tuf gene sequencing correctly identified all
of the reference strains and 61 clinical isolates included in
the present study.
We studied the utility of Rapid ID 32 Strep, API Strep,
Fluo-Card Milleri, and Wee-tabs for the identification of the
AGS. Our biochemical test results were generally in
agreement with those reported earlier [1, 7, 13]. The Rapid
ID 32 Strep proved to be most useful in separating the three
AGS species (Table 2). S. intermedius could readily be
differentiated from the other two species by Rapid ID 32
Strep β-galactosidase and β-NAG reactions; this result is
unlike that reported by Limia et al. l [11], who found that
only 57% of the S. intermedius strains were correctly
identified by the Rapid ID 32 Strep test. Three of the S.
anginosus strains tested gave red-orange (positive) reaction
in the Rapid ID 32 Strep resorufin-βD-galactopyranoside
test (well 1.2), whereas the 2-naphthyl-βD-galactopyrano-
side test (well 0.2) yielded a pale purple color, which would
be interpreted as negative. Wee-tabs β-fucosidase, β-NAG,
and ONPG readily separated S. intermedius (all positive)
from the other two species (all negative). The Rapid ID 32
Strep β-glucosidase reaction could be used to separate S.
anginosus strains from S. constellatus; all β-glucosidase-
negative strains were S. constellatus. Our Fluo-Card Milleri
results are not in complete agreement with previous reports
[10, 13]. All S. intermedius strains were correctly identi-
fied; however, 55% of the S. anginosus strains also showed
β-fucosidase activity with this method, and would, there-
fore, be identified as S. intermedius by Fluo-Card (Table 3).
Unlike S. intermedius, all β-fucosidase-positive S. anginosus
strains were β-glucosidase-negative, which could be used as
a distinguishing characteristic between these two species.
Our results also indicate that 24% of S. constellatus are
β-glucosidase-positive in the Fluo-Card Milleri test and,
therefore, could be misidentified.
In conclusion, both 16S rRNA gene and tuf gene
sequencing can be used for the reliable identification of
the AGS. If using 16S rRNA gene sequencing for the
identification of the AGS, care must be taken to compare
the sequences only to those of well characterized strains in
GenBank. S. intermedius could readily be differentiated
from the other two species by biochemical tests, such as the
Rapid ID 32 Strep and Wee-tab β-NAG and ONPG tests.
Biochemical tests, such as the Rapid ID 32 Strep β-
glucosidase reaction, are useful in the differentiation of S.
anginosus from S. constellatus; however, in some cases,
16S rRNA gene or tuf gene sequencing is needed to
separate these two species.
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